|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
After brief cognitive testing and the Delirium Symptom Interview, delirium and delirium severity were rated daily in the hospital using the Confusion Assessment Method (CAM) and CAM-Severity score, the Delirium Rating Scale-Revised-98 (DRS-R-98), and the Memorial Delirium Assessment Scale (MDAS).
|
30032141 |
2019 |
|
Delirium
|
0.100 |
Biomarker
|
disease |
BEFREE |
Higher severity of delirium as indicated by the total DRS-R98 score and the total DRS-R98 severity score were associated with higher severity of PTSD symptoms.
|
31376870 |
2019 |
|
Delirium
|
0.100 |
Biomarker
|
disease |
BEFREE |
Primary endpoint was delirium response rate (DRR), defined as number of patients with DRS-R-98 severity score <15.25 and ≥4.5 points reduction.
|
31801901 |
2019 |
|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this prospective cohort study, 225 intensive care patients with Richmond Agitation and Sedation Scale (RASS) scores of -1 - drowsy and 0 - alert and calm were evaluated with the Delirium Rating Scale-Revised-1998 (DRS-R-98) and the Diagnostic and Statistical Manual 4th edition text revision (DSM-IV-TR)-determined diagnosis of delirium.
|
31535614 |
2019 |
|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Patients with advanced cancer admitted to the medical oncology ward were screened for delirium with the DOS and DRS-R-98.
|
30782151 |
2019 |
|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Neither median delirium/coma-free days (P = .361) nor median change in delirium severity scores (P = .582 for DRS-R-98; P = .333 for CAM-ICU-7) were different between groups.
|
30664239 |
2019 |
|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The ability of the DRS-R-98 items to discriminate between either form of delirium was substantial.
|
28262089 |
2018 |
|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Harmonization of delirium severity instruments: a comparison of the DRS-R-98, MDAS, and CAM-S using item response theory.
|
30200896 |
2018 |
|
Delirium
|
0.100 |
Biomarker
|
disease |
BEFREE |
Medical inpatients of ≥70 years were assessed on admission for delirium using the Revised Delirium Rating Scale (DRS-R98) and those with prevalent delirium were excluded.
|
29966197 |
2018 |
|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
DRS-R-98 items were subgrouped to represent subscores representing the three core domains of delirium (cognitive, higher-order thinking, and circadian), noncore accessory symptoms (psychotic and affective), and diagnostic characteristics (temporal onset, fluctuation, and physical disorder).
|
30045679 |
2018 |
|
Delirium
|
0.100 |
Biomarker
|
disease |
BEFREE |
Discharge to a care home was associated only with DRS-R98 defined delirium.
|
28903799 |
2018 |
|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Delirium severity was assessed using Delirium Rating Scale Revised-98 (DRS-R-98) and Cognitive Assessment Method severity score (CAM-sev).
|
27917740 |
2017 |
|
Delirium
|
0.100 |
Biomarker
|
disease |
BEFREE |
DRS-R98 profiles were essentially the same in delirium and SSD subgroups with or without dementia, although total scale scores were generally higher when in comorbid subgroups.
|
28116342 |
2017 |
|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Delirium was defined with DRS-R98 (score > 16) and recovery from delirium as ≥2 consecutive assessments without delirium prior to discharge.
|
28280733 |
2017 |
|
Delirium
|
0.100 |
Biomarker
|
disease |
BEFREE |
The longitudinal relationship between DRS-R98 and Richards-Campbell Sleep Quality Scale sleep scores and delirium, also with dementia as a covariate, was evaluated using generalized estimating equation logistic regression.
|
28275701 |
2017 |
|
Delirium
|
0.100 |
Biomarker
|
disease |
BEFREE |
The severity of delirium symptoms was assessed daily using the Delirium Rating Scale - Revised-98 (DRS-R-98).
|
28243098 |
2017 |
|
Delirium
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Similarly lower levels of IGF-I, and high levels of IFN-gamma, are statistically significantly (P < 0.05) associated with higher DRS scores (more severe delirium).
|
19269948 |
2009 |